rxstat › Shortages › Irbesartan

Irbesartan shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Irbesartan products are in shortage in Canada (10 of 43 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 30, 2022.
Products affected
10 / 43
In shortage since
Sep 17, 2018
Est. full return
Dec 30, 2022
Reports on file
160
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
JAMP-IRBESARTAN
75MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418193 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-IRBESARTAN
150MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418207 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-IRBESARTAN
150MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418207 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-IRBESARTAN
300MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418215 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-IRBESARTAN
75MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418193 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-IRBESARTAN
300MG · TABLET · JAMP PHARMA CORPORATION
DIN 02418215 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
BIO-IRBESARTAN
300MG · TABLET · BIOMED PHARMA
DIN 02446162 · since Mar 12, 2019, no end estimate · Delay in shipping of the drug.
Active shortage
BIO-IRBESARTAN
150MG · TABLET · BIOMED PHARMA
DIN 02446154 · since Mar 10, 2019, no end estimate · Delay in shipping of the drug.
Active shortage
BIO-IRBESARTAN
75MG · TABLET · BIOMED PHARMA
DIN 02446146 · since Sep 17, 2018, no end estimate · Demand increase for the drug.
Active shortage
APO-IRBESARTAN
75MG · TABLET · APOTEX INC
DIN 02386968 · since Nov 5, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
AURO-IRBESARTAN
75MG · TABLET · AURO PHARMA INC
DIN 02406098 · since Oct 17, 2018, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
AURO-IRBESARTAN
150MG · TABLET · AURO PHARMA INC
DIN 02406101 · since Oct 17, 2018, no end estimate · Requirements related to complying with good manufacturing practices.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Irbesartan is currently affected by 10 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, BIOMED PHARMA, APOTEX INC, AURO PHARMA INC.

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug; demand increase for the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Irbesartan is classified under “ANGIOTENSIN II ANTAGONISTS, PLAIN” (ATC C09CA).

Recent changes

Common questions

When will Irbesartan be back in stock in Canada?

The latest manufacturer estimate is Dec 30, 2022. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Irbesartan in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (angiotensin ii antagonists, plain)

Partial shortageCandesartan Cilexetil20 of 59 reported products affected · est. return Dec 31, 2020Partial shortageLosartan16 of 45 reported products affected · est. return Dec 31, 2026Partial shortageOlmesartan Medoxomil2 of 24 reported products affectedPartial shortageTelmisartan3 of 26 reported products affectedPartial shortageValsartan3 of 43 reported products affected · est. return Jun 19, 2026No current shortageAzilsartan Medoxomil

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.